Skip to content

September 24-26
San Diego, USA

Be part of the device engineering evolution: 
From PFS to smart injectors to delivering
quality patient care

AgendaFull Event Guide

Full Event Guide

The parenteral combination products market is fiercely competitive, especially with the rise of chronic disease, generics and biosimilars. While PFS and autoinjectors are in high demand, drug and device developers continue to invest their efforts in refining device design, validation and primary packaging.

Every incremental step will bring us closer to a leap – take a look at your complimentary event guide to find out how Bill & Melinda Gates Foundation, Genentech, Teva, Novartis, Merck, Janssen, Gilead Sciences and Biogen are committed to making a change to better serve patients.

Injectables snippet